This Market Study was carried out during my internship training period at Wallace Pharmaceuticals, India, Pvt. Ltd.
it is a presentation proposal to the company in view of making future investment in the Philippine Pharmaceutical Market.
The Philippines pharmaceutical market is a complex institution owing to its expensive medical care, monopolistic competition, and lack of government controlled drug pricing, all within a country that has high levels of poverty.
The research study delves further into the pharmaceutical market, methods of investment and the advantages of investment in the said market.
N.B: This presentation is based solely on secondary internet research. Though 100% accurate and cited, some information (figures) are dated due to lack of current and up to date information availability on the internet.
The presentation is part of a market research study.
This Market Study was carried out during my internship training period at Wallace Pharmaceuticals, India, Pvt. Ltd.
it is a presentation proposal to the company in view of making future investment in the Philippine Pharmaceutical Market.
The Philippines pharmaceutical market is a complex institution owing to its expensive medical care, monopolistic competition, and lack of government controlled drug pricing, all within a country that has high levels of poverty.
The research study delves further into the pharmaceutical market, methods of investment and the advantages of investment in the said market.
N.B: This presentation is based solely on secondary internet research. Though 100% accurate and cited, some information (figures) are dated due to lack of current and up to date information availability on the internet.
The study is accompanied by a slideshow presentation.
The Philippines' Pharmaceutical Market: A Secondary Research StudyNadia Dias
This Market Study was carried out during my internship training period at Wallace Pharmaceuticals, India, Pvt. Ltd.
it is a presentation proposal to the company in view of making future investment in the Philippine Pharmaceutical Market.
The Philippines pharmaceutical market is a complex institution owing to its expensive medical care, monopolistic competition, and lack of government controlled drug pricing, all within a country that has high levels of poverty.
The research study delves further into the pharmaceutical market, methods of investment and the advantages of investment in the said market.
N.B: This presentation is based solely on secondary internet research. Though 100% accurate and cited, some information (figures) are dated due to lack of current and up to date information availability on the internet.
The study is accompanied by a slideshow presentation.
This Market Study was carried out during my internship training period at Wallace Pharmaceuticals, India, Pvt. Ltd.
it is a presentation proposal to the company in view of making future investment in the Philippine Pharmaceutical Market.
The Philippines pharmaceutical market is a complex institution owing to its expensive medical care, monopolistic competition, and lack of government controlled drug pricing, all within a country that has high levels of poverty.
The research study delves further into the pharmaceutical market, methods of investment and the advantages of investment in the said market.
N.B: This presentation is based solely on secondary internet research. Though 100% accurate and cited, some information (figures) are dated due to lack of current and up to date information availability on the internet.
The study is accompanied by a slideshow presentation.
The Philippines' Pharmaceutical Market: A Secondary Research StudyNadia Dias
This Market Study was carried out during my internship training period at Wallace Pharmaceuticals, India, Pvt. Ltd.
it is a presentation proposal to the company in view of making future investment in the Philippine Pharmaceutical Market.
The Philippines pharmaceutical market is a complex institution owing to its expensive medical care, monopolistic competition, and lack of government controlled drug pricing, all within a country that has high levels of poverty.
The research study delves further into the pharmaceutical market, methods of investment and the advantages of investment in the said market.
N.B: This presentation is based solely on secondary internet research. Though 100% accurate and cited, some information (figures) are dated due to lack of current and up to date information availability on the internet.
The study is accompanied by a slideshow presentation.
Teaching the history of pharmacy to young people is a challenge but it can be done if delivered in an interesting and engaging way. These slides summarize what I share with my students.
Before you start writing your pharmacy business plan, spend as much time as you can to reading through some samples of a medical and health care business plans. Not only will that give you a good idea of what it is you’re aiming for, but it will also show you the different sections that different entrepreneurs include and the language they use to write about themselves and their future plans.
We have created a sample pharmacy business plan example for you to get a good idea about how a perfect pharmacy business plan should look like and what details you should include in your business plan.
Source: https://upmetrics.co/template/pharmacy-business-plan-example
A brief description about International marketing, nature of international marketing, evaluating international marketing, develop international marketing objectives,product marketing strategies
Teaching the history of pharmacy to young people is a challenge but it can be done if delivered in an interesting and engaging way. These slides summarize what I share with my students.
Before you start writing your pharmacy business plan, spend as much time as you can to reading through some samples of a medical and health care business plans. Not only will that give you a good idea of what it is you’re aiming for, but it will also show you the different sections that different entrepreneurs include and the language they use to write about themselves and their future plans.
We have created a sample pharmacy business plan example for you to get a good idea about how a perfect pharmacy business plan should look like and what details you should include in your business plan.
Source: https://upmetrics.co/template/pharmacy-business-plan-example
A brief description about International marketing, nature of international marketing, evaluating international marketing, develop international marketing objectives,product marketing strategies
Essential medicines, as defined by the World Health Organization (WHO) are "those drugs that satisfy the health care needs of the majority of the population; they should therefore be available at all times in adequate amounts and in appropriate dosage forms, at a price the community can afford
OVEARVIEW OF NON-COMMUNICABLE DISEASES IN LEOTHO SEJOJO PHAAROE
Chronic non infectious diseases that are silent and persecute mankind . non-communicable disease (NCD) is a disease that is not transmissible directly from one person to another. NCDs include Parkinson's disease, autoimmune diseases, strokes, heart diseases, cancers, diabetes, chronic kidney disease, osteoarthritis, osteoporosis, Alzheimer's disease, cataracts, and other
Epilepsy Drugs Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Op...IMARC Group
The global epilepsy drugs market size reached US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.16% during 2024-2032.
More Info:- https://www.imarcgroup.com/epilepsy-drugs-market
Dr. Michael S. Perry - Afternoon Keynote Presentationmarsinnovation
Afternoon Keynote Presentation
Dr. Michael S. Perry, Venture Partner, Bay City Capital; President and Chief Medical Officer, Poniard Pharmaceuticals (US)
MaRS Innovation Summit
October 28, 2010
Presentation by Kenneth I. Kaitin, PhD, Professor and Director, Tufts Center for the Study of Drug Development, Tufts University School of Medicine at the marcus evans Evolution Summit Fall 2015 in Las Vegas
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.
a presentation in CME activities by Saad Specialist Hospital, KSA
The intensifying global focus on oncology reflects its increasing impact on patients and expanding share of healthcare expenditure. Relative to other parts of the healthcare system, oncology brings high levels of uncertainty—in terms of the nature and rate of innovative treatments, the willingness by payers to reimburse care at current levels, and the shifting composition of the cancer patient population from mature and developed markets to low- and middle-income countries. As the sales of cancer treatments rise to $100 billion annually, more intensive scrutiny of this market can be expected and a deeper understanding of global oncology trends will be required by all stakeholders.
Global Apheresis Market Analysis Sample ReportInsights10
The Global apheresis market is projected to grow from $3.6 Mn in 2022 to $6.4 Mn in 2030 with a CAGR of 8% for the year 2022-2030. Growth of the market will be mainly driven by the rising prevalence of chronic diseases and a growing number of trauma and injury cases. Fresenius Kabi and Terumo are key players in the market. To get a detailed report, contact us at - info@insights10.com
Policy and practice: Developing countries and livestock drug useILRI
Presented by Delia Grace, Hung Nguyen, Purvi Mehta, Johanna Lindahl and Manish Kakkar at the 3rd international conference on responsible use of antibiotics in animals, Amsterdam, the Netherlands, 29 September - 1 October 2014.
Opportunities & Challenges in West Africa's (Ghana & Nigeria) Healthcare and ...Aiswariya Chidambaram
This presentation made at the Pharma Insights Briefing session of CPhI Worldwide 2014, Paris, provides information on the market opportunities of
the fastest growing pharmaceutical markets in Africa: Ghana and Nigeria.
• Market sizing and Growth Trends
• Key Merger, Acquisition and Partnership Assessment
• Market Drivers and Challenges
• Pharmaceutical Procurement, Supply, Distribution and Retail
• SWOT and PESTLE Analysis
• Competitive Landscape Analysis
• Therapeutic Area Growth Analysis
• Strategic Recommendations
Similar to The philippines market research presentation (20)
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
1. THE PHILIPPINES:
A PHARMACEUTICAL MARKET
RESEARCH STUDY
Nadia Dias, Marketing Intern
Guide: Francis Pires, Business Head-International Division
2. PART I: AN INTRODUCTION TO THE DEMOGRAPHIC LANDSCAPE
OF THE PHILIPPINES
• Introduction
• The Demographic Landscape of the Philippines
• Political Context
• Economy
• Healthcare in the Philippines
• Pharmaceutical Supply Chain
• Medical Human Resource Statistics
PART II: THE PHARMACEUTICAL MARKET IN THE PHILIPPINES
• The Pharmaceutical Market in the Philippines
• Product Registration
• Pharmaceutical Importers
• Manufacturers and Distributors
• Foreign Companies in the Philippines
• Pharmaceutical Retailers in the Philippines
• Pricing Regulation for the Private Sector
CONTENTS
3. • South-East Asian Archipelago.
• 7,107 Islands.
• Capital City-Manila.
• 2,000/7,107 Islands Inhabited.
• Urban Population: 31.8% to 50.32% (last 3 decades).
• Fragmentary nature of Islands- challenge to trade and
commerce in the country.
• Economy resilient to global shocks due to , lower dependence
on exports, relatively resilient domestic consumption, large
remittances.
• 1 PHP (Filipino Peso)=0.020 USD=1.37 INR
INTRODUCTION
4.
5. • Population: 102,624,209
• Growth Rate: 1.59%
• Per Capita Income (IMF 2015): $7,282
• GDP: USD 2,765
• Death Rate: 6.1 deaths/1000 population
0-4 years: 33.7%
5-24 years: 19.17% Male population larger than female population
25-54 years: 36.86%
55-64 years: 5.89%
65 & above: 4.38% Female population larger than male population
DEMOGRAPHIC LANDSCAPE
7. • Executive Branch: administrative/regulatory authority
over health systems.
• Legislative Branch: approving annual budgets and
allocating development funds.
• Dept. of Health (DOH): regulation and facilitation of
health systems and processes in the Philippines.
POLITICAL CONTEXT
8. • 2011-2016- 6% economic growth.
• FDI growth- lags behind regional peers.
• ¼ of the Filipino population lives in poverty.
• 50% <$2/day
THE ECONOMY
9. • Health Outcomes-Lags behind most of South-East
Asia and North Asia
• Health Index UNDP-Rank 117, 0.749
• Social and geographic barriers- inequitable access
to resources.
• Lower-income families and less developed areas-
poor health status
• Life expectancy in richer provinces is more than 10
years longer than in poorer ones
HEALTHCARE
11. Number/Rate per 100,000 Population-5-Year Average (2008-
2012) and 2013
Cause of Death 5-Year Average (2008-12) 2013
Number Rate Number Rate
Diseases of the Heart 1,03,170 110.3 1,18,740 121.1
Diseases of the Vascular System 66,754 71.4 68,325 69.7
Malignant Neoplasms 49,016 52.4 53,601 54.7
Pneumonia 45,303 48.4 53,101 54.2
Accidents 36,100 38.6 40,071 40.9
Diabetes Mellitus 22,287 23.9 27,064 27.6
Chronic Lower Respiratory Diseases 23,005 24.6 23,867 24.4
Tuberculosis, all forms 24,362 26.1 23,216 23.7
Nephritis, Nephrotic Syndrome & Nephrosis 13,599 14.6 14,954 15.3
Certain Conditions Originating from the Perinatal
Period
11,904 12.8 10,436 10.6
17. PHARMACEUTICAL SUPPLY CHAIN
• Monopolistic pricing exists in drug sales in
hospitals.
• Drug prices in hospitals double those in retail
pharmacies
• Access to essential drugs- constrained due to
limited availability and high costs
• Availability depends on presence of doctors and
drugstores in the region
• Doctor prescriptions must be signed by pharmacist-
implementation is difficult
18. • 1988-Generic Drugs Act to make drugs more affordable
• Failed to encourage use of generic drugs
• Lack of information on safety and efficacy
• Essential Drugs List established
• 2009-DOH set Max. Retail Drug Prices for selected drugs
• 1987-Philippines National Drug Policy (PNDP)
• PNDP-Ensure quality and drugs and availability and affordability to all
sections of the Filipino population.
• Essential Drugs List/Philippines National Drug Formulatory set
standards for procurement of drugs in the government sector.
• Generics Act 2008-Compulsory Licensing, Parallel Importation, Price
Control, generic substitution
• Regulatory Reforms supported Botika ng Barangays Programme
(BnB)-Sold drugs @ 62% cheaper
PHARMACEUTICAL SUPPLY CHAIN
19. SUPPLY CHAIN: MNCs
● Pharmaceutical MNCs are mainly drug traders
● Import large amounts of their merchandise from
abroad
● Giant MNCs hire manufacturing services of
InterPhil (Toll Manufacturer)
● Zuellig-mostly distribution of MNCs drug products
22. SUPPLY CHAIN: LOCAL MANUFACTURERS AND
TRADERS
● Local Pharma sector-mix of manufacturers and
traders
● Top 20 list-only 4 local companies
● Local giant- United Laboratories owns 28% local
sales
25. FOREIGN SUBSIDIARY
MANUFACTURERS
Interphil
TOLL MANUFACTURERS
Hizon Labs
Swiss Pharma
Euro-Med Laboratories
Lloyd Laboratories
Ace Pharmaceuticals
Allied
LOCAL MANUFACTURERS
Pascual Laboratories
United Laboratories
Asian antibiotics
Amherst
Westmont
AM-Europharma
AD-Drugstel
Euromed
IMPORTATION AND TRADING
GSK
Bristol Myers Squibb
Natrapharm
GX International
Medhaus Pharma
Prohealth Pharma
Cathay Drug
Pascual Laboratories
United Laboratories
MANUFACTURERS
26. DRUG SUPPLY CHAIN
● MNCs-more trading/marketing/distribution rather
than manufacturing
● Manufacturing-highly concentrated-one toll
manufacturer-InterPhil
● Distribution concentrated-Zuellig
● Locals- some only manufacturing
● some locals-manufacture & trade & distribute
27. SHARE OF THE TOP THERAPEUTIC
CLASSES TOTAL PHARMA
31. THE PHILIPPINES’ PHARMACEUTICAL MARKET
➔ Last decade- growth rate-12-14% annually
➔ 2014-Filipino drug market-$4.3 billion
➔ At par with Taiwan and indonesia
➔ Increase at 4.9% CAGR-$8 billion in 2020
➔ 3.93% market share in Asia Pacific pharmaceutical
market
➔ 0.31%-Global Market Share
➔ Generic substitution in private and public sector-driver
for manufacture of generic drugs
➔ Increased expenditure on medicines by Clocal
Government Units
➔ 2012-foreign pharmaceutical companies-70% of Filipino
pharmaceutical market
32. THE PHILIPPINES’ PHARMACEUTICAL MARKET
● GlaxoSmithKline, Novartis, Sanofi-largest foreign
companies doing business in the Philippines
● Local companies- United Laboratories, Pascual
Laboratories, GC International, Natrapharm
● Generic segment-Sandoz (Novartis), Orient
Europharma (Taiwan), Getz Pharma (Pakistan)
● Multinationals-reducing priceso drugs-50% to
compete with generic products
● Drug prices in Philippines-still remain highest in
Asia
33. Why are drug prices so high?
➔ Poor purchasing practices in Filipino hospitals.
➔ High Retail Markups because of monopolistic competition
➔ Prohibitive cost of importing pharmaceutical ingredients
➔ Low rates of health insurance
➔ Low rates of coverage for out-patient drugs
➔ 2008-Universally Accessible Cheaper and Quality
Medicines Act-power to impose Max. retail price on drugs
mentioned in the essential drugs list
➔ Philippines Respects International Property Rights (IPR)
➔ Cannot simply introduce generics that are under patent
34. PRODUCT REGISTRATION
➔Companies that are involved in the manufacture,
import, export, distribution, retailing, packaging and
re-packaging of pharmaceuticals
➔Companies require a Licence to Operate (LTO)
before registering their product with the FDA
➔Licence to Operate (LTOs) from the manufacturer,
distributor and / or importer
➔A Certificate of Agreement between the
manufacturer and distributor or the manufacturer
and importer for the product being registered
➔The Application for Registration of Pharmaceutical
form
35. PRODUCT REGISTRATION
● Information on product formulation and dosage
● A Certificate of Analysis and Specifications for all raw
materials
● Information on the manufacturing process, including
procedure, in-process controls, production equipment and
packaging procedure
● Labelling materials
● Stability studies
● A product sample (which should include English labels for
the product registration number, the generic and brand
names, the name of the product license holder,
indications for use, dosage, warnings and precautions, the
batch number and the expiration date)
36. PRODUCT REGISTRATION
• Rules and regulations for import of pharmaceutical goods
• Follow registration procedure
• Registration completed in the name of local
distributor/consultant lawyer
• Despite payment for registration, direct rights over
product (marketing/distribution)
• Can own rights to goods only once a Philippines arm of
the company is established
• Import goods of its own registration
38. PHARMACEUTICAL IMPORTERS
• Filipino pharmaceutical market heavily dependent on import of
raw and finished pharmaceutical products
• Few foreign companies manufacture in Philippines
• Import and distribute finished products
• Import raw materials and outsource production to local
manufacturers
• Authorizations required to import pharmaceutical drugs
• 2000-Parallel Drug Importation Pharma Plan 50
• Philippines International Trade Corporation (PITC)-Source off-
patent drugs from essential drugs list
• Imports-Primarily from India-competed with prices of branded
products
• Plan failed-limited volume of imports and weak distribution
network
40. PHARMACEUTICAL MANUFACTURING
• One domestic manufacturer dominates
manufacturing for most foreign pharmaceutical
companies
• Interphil Laboratories- Zuellig Family Trust
Companies- contracts from 15 to 20 foreign
companies
• 2009-90% of Wyeth’s drug manufacturing in the
Philippines+all local manufacturing for Pfizer
• Unilab (United Laboratories)- largest individual
share in the domestic market
41. PHARMACEUTICAL MANUFACTURING
● All domestic and international manufacturing
facilities producing drugs for the Philippines'
market are required to meet Filipino Good
Manufacturing Practice (GMP) standards
● domestic companies generally do not produce
active substances but are limited to activities such
as compounding active substances, packing bulk
drugs into dosage forms, processing simple galenic
medicinals into final drug form, and diluting
concentrated extracts to marketable strengths.
42. PHARMACEUTICAL MANUFACTURING
● gain access to new drugs either through their
domestic offices abroad or through licensing
agreements with foreign pharmaceutical
manufacturers.
● The percentage of market share by volume
produced by domestic manufacturers is 48%
44. PHARMACEUTICAL DISTRIBUTORS
• Most distribution takes place through two major local
companies – Zuellig Pharma and Metro Drug-85%
Distribution Channels in Philippines
• Do not have to comply with Good Distributing Practice
(GDP) standards
• Some companies are engaged in manufacture and
disstribution-EON Pharmatek and Biomed Pharma Inc.
• The Philippines Pharmaceutical Manufacturers Association
(PPMA) is a non-stock, non-profit association.
• It was organized for the primary purpose of bringing
together entities engaged in the manufacture and/or
marketing of pharmaceutical products.
•
46. FOREIGN COMPANIES IN THE PHILIPPINES
• ¾ of the top 20 companies in the Philippines are foreign.
• Control 66% of total industry sales
• Market shares of individual companies: 1-6%
• Only 30%of pharmaceutical sales are accounted for by
domestic Filipino companies
• GlaxoSmithKline has its largest MNC manufacturing
facility in Philippines- exports to rest of SE Asia
Companies 2003 2004 2005 2006 2007
Local 208 210 224 224 240
Foreign 165 171 194 203 231
48. PHARMACEUTICAL RETAILERS IN THE PHILIPPINES
• Pharma retail: Generic and Branded
• Generic Drugs: Less expensive-cost 30-80% less
than their branded counterparts
• Sale of generic or branded drug at a particular
pharmacy depends on the type of pharmacy
Generic Pharmacies:
• The Generics Pharmacy
• Generika Generics
• My Botika
• Botika ng Bayan
Chain Retail Pharmacies:
• Mercury Drug
• Rose Pharmacy
• Watsons
• South Star Drug
• United Pharm
• Cherub's Face Pharmacy and
Medical Supplies
• KChan Pharmacy
• New Lords Pharmacy
• Caslim Pharmacy and General
Merchandise
50. WHY INVEST IN THE FILIPINO
PHARMACEUTICAL MARKET?
● Archipelagic nature places a premium on logistics.
● Value of market in 2020- $ 8 billion
● Foreign investment- 70%
● Discrepancy between generic and branded drug
prices
● Monopolistic competition and open pricing
● Generic Drugs Act- does not apply to private
companies
● Respect for Intellectual Property Rights
51. WHY INVEST IN THE FILIPINO
PHARMACEUTICAL MARKET?
● Per capita income of Filipino population $ 7282
● Population consumes higher percentage of branded
drugs
Country Dose Manufacturer Branded/Generic Price
India 250 mg/100 tab SmithKline Beecham Amoxil $ 10
Philippines 250 mg/100 tab SmithKline Beecham Amoxil $ 25
India 150 mg/100 tab Glaxo Zantac $ 3
Philippines 150 mg/100 tab Glaxo Zantac $ 95
52. WHY INVEST IN THE FILIPINO
PHARMACEUTICAL MARKET?
● 11th largest in Asia Pacific
● 3rd largest in ASEAN
● Thailand-generic manufacturing
● Philippines- larger market share- value/unit
● Offers higher value per unit
● Potential to create and sustain brands